Výsledky vyhledávání - "recombinant recombinant factor VII activated"

A comparison between on-demand usage of rFVIIa vs prophylaxis use of emicizumab in high titer inhibitory hemophilia A patients in Iran

Autor: Saiyarsarai, Parisa, Robabpour Derakhshan, Atefeh, Khedmati, Jamaleddin, Eshghi, Peyman, Seyedifar, Meysam

Publikováno v: Medicine

Background: Hemophilia A (HA) is an inherited X-linked bleeding disease with costly treatment, especially for high titer inhibitory patients. Emicizumab, a new humanized bispecific antibody, has been approved for use to prevent or reduce the frequenc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::6710688bff0895ee84056121168e7cc8
http://europepmc.org/articles/PMC8500655

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání